...
首页> 外文期刊>Organic & biomolecular chemistry >Proof of concept for poor inhibitor binding and efficient formation of covalent adducts of KRAS~(G12C) and ARS compounds
【24h】

Proof of concept for poor inhibitor binding and efficient formation of covalent adducts of KRAS~(G12C) and ARS compounds

机译:抑制剂结合不良和有效形成KRAS〜(G12C)与ARS化合物共价加合物的概念证明

获取原文
获取原文并翻译 | 示例

摘要

The use of selective covalent inhibitors with low binding affinity and high reactivity with the target enzyme is a promising way to solve a long-standing problem of the "undruggable" RAS-like proteins. Specifically, compounds of the ARS family that prevent the activation of the GDP-bound G12C mutant of Kirsten RAS (KRAS) are in the focus of recent experimental research. We report the first computational characterization of the entire reaction mechanism of the covalent binding of ARS-853 to the KRAS~(G12C). GDP complex. The application of molecular dynamics, molecular docking and quantum mechanics/molecular mechanics approaches allowed us to model the inhibitor binding to the protein and the chemical reaction of ARS-853 with Cysl2 in the enzyme binding site. We estimated a full set of kinetic constants and carried out numerical kinetic analysis of the process. Thus, we were able to compare directly the physicochemical parameters of the reaction obtained in silico and the macroscopic parameters observed in experimental studies. From our computational results, we explain the observed unusual dependence of the rate constant of covalent complex formation, k_(obs), on the ARS concentration. The latter depends both on the non-covalent binding step with the equilibrium constant, K,, and on the rate constant of covalent adduct formation, k_(inact). The calculated ratio k_(inact)/K_i = 213 M~(-1)s~(-1) reproduces the corresponding experimental value of 250 ± 30 M~(1) s~(-1) for the interaction of ARS-853 with KRAS~(G12C) Electron density analysis in the reactive region demonstrates that covalent bond formation occurs efficiently according to the Michael addition mechanism, which assumes the activation of the C=C bond of ARS-853 by a water molecule and Lysl6 in the binding site of KRAS~(G12C). We also refine the k_(inact) and K_i constants of the ARS-107 compound, which shares common features with ARS-853, and show that the decrease in the k_(inact)/K_i ratio in the case of ARS-107 is explained by changes in both K_i and k_(inact) constants.
机译:具有低结合亲和力和与靶酶的高反应性的选择性共价抑制剂的使用是解决长期存在的“不可负担的” RAS样蛋白问题的有前途的方式。特别地,防止Kirsten RAS(KRAS)的GDP绑定的G12C突变体的激活的ARS家族化合物是近期实验研究的重点。我们报道了ARS-853与KRAS〜(G12C)共价结合的整个反应机理的第一个计算特征。 GDP复合体。分子动力学,分子对接和量子力学/分子力学方法的应用使我们能够对抑制剂与蛋白质的结合以及ARS-853与Cysl2在酶结合位点的化学反应进行建模。我们估计了一整套动力学常数,并对过程进行了数值动力学分析。因此,我们能够直接比较在硅胶上获得的反应的理化参数和实验研究中观察到的宏观参数。从我们的计算结果中,我们解释了共价复合物形成速率常数k_(obs)对ARS浓度的异常依赖性。后者既取决于具有平衡常数K的非共价结合步骤,又取决于共价加合物形成的速率常数k_(inact)。计算出的比率k_(inact)/ K_i = 213 M〜(-1)s〜(-1)再现了ARS-853相互作用的相应实验值250±30 M〜(1)s〜(-1) KRAS〜(G12C)反应区的电子密度分析表明,根据迈克尔加成机理有效地发生了共价键形成,这假定了水分子和结合中的Lysl6激活了ARS-853的C = C键KRAS〜(G12C)的网站。我们还细化了与ARS-853具有共同特征的ARS-107化合物的k_(inact)和K_i常数,并表明可以解释ARS-107情况下k_(inact)/ K_i比值的降低通过改变K_i和k_(inact)常数。

著录项

  • 来源
    《Organic & biomolecular chemistry》 |2020年第16期|3069-3081|共13页
  • 作者单位

    Department of Chemistry Lomonosov Moscow State University Moscow 119991 Russian Federation Bach Institute of Biochemistry Research Center of Biotechnology Russian Academy of Sciences Moscow 119071 Russian Federation;

    Department of Chemistry Lomonosov Moscow State University Moscow 119991 Russian Federation;

    Department of Chemistry Lomonosov Moscow State University Moscow 119991 Russian Federation Emanuel Institute of Biochemical Physics Russian Academy of Sciences Moscow 119334 Russian Federation;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号